Riskpilot← Back to searchSign inGet full accessSoop Medical AB
ABActiveOrg 5592292170Matrosvägen 1Business and other management consultancy activities · NACE 7020Est. 20191 employees
Revenue 2024
SEK 21K
EBITDA margin
50.3%
+133% vs 2023
Equity ratio
91.4%
Financial strength
Net profit 2024
SEK 25K
+1508% vs 2023
| Revenue | SEK 21K | — |
| EBITDA | SEK 11K | +133% |
| Net profit | SEK 25K | +1508% |
| Total assets | SEK 94K | +6% |
| Equity | SEK 86K | +41% |
| Employees | 1 | — |
Legal name
Soop Medical AB
Org number
5592292170
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
2 december 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolagen ska bedriva konsultverksamhet inom medicinsk vetenskap och avtalsjuridik samt förvalta värdepapper och egendom.
Address
Matrosvägen 1
Email
lourde.soop@mac.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 093 | 0 | 24 | 0 | 21 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | 601 | 22 | 13 | −32 | 11 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 601 | 22 | 13 | −32 | 11 |
| Net financials | −29 | — | −0 | 1 | 1 |
| Profit before tax | 437 | 107 | 13 | −2 | 31 |
| Tax | −94 | −23 | −3 | — | −7 |
| Net profit | 343 | 84 | 10 | −2 | 25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 650 | 264 | 123 | 89 | 94 |
| Equity | 393 | 138 | 62 | 61 | 86 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 122 | 76 | 11 | 8 | 8 |
| Total debt | 122 | 76 | 11 | 8 | 8 |
EBITDA margin
50.3%
This company
15.8%
Market median
+218% vs market
20202024
Equity ratio
91.4%
This company
38.2%
Market median
+139% vs market
20202024
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
20202024
Net profit margin
115.9%
This company
8.1%
Market median
+1331% vs market
20202024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Soop Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Peter Oskar Norlén | Deputy Board Member | 0 companies |
| Lourde Anne Soop | Chairman | 0 companies |
| Mattias Soop | Board of Directors | 0 companies |